Brookstone Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.87M Buy
14,820
+6,774
+84% +$857K 0.02% 432
2025
Q1
$1.03M Buy
8,046
+12
+0.1% +$1.54K 0.01% 547
2024
Q4
$1.06M Sell
8,034
-973
-11% -$129K 0.02% 515
2024
Q3
$1.31M Sell
9,007
-11,110
-55% -$1.62M 0.02% 450
2024
Q2
$2.94M Buy
20,117
+13,488
+203% +$1.97M 0.05% 310
2024
Q1
$910K Sell
6,629
-124
-2% -$17K 0.02% 509
2023
Q4
$917K Buy
6,753
+269
+4% +$36.5K 0.02% 479
2023
Q3
$763K Buy
6,484
+3,925
+153% +$462K 0.02% 484
2023
Q2
$318K Buy
2,559
+576
+29% +$71.6K 0.01% 673
2023
Q1
$265K Sell
1,983
-6,382
-76% -$852K 0.01% 718
2022
Q4
$1.11M Sell
8,365
-600
-7% -$79.9K 0.02% 409
2022
Q3
$1.07M Buy
8,965
+6,982
+352% +$831K 0.02% 384
2022
Q2
$251K Sell
1,983
-1,268
-39% -$160K 0.01% 683
2022
Q1
$423K Buy
3,251
+751
+30% +$97.7K 0.01% 587
2021
Q4
$351K Sell
2,500
-1,893
-43% -$266K 0.01% 591
2021
Q3
$684K Sell
4,393
-1,088
-20% -$169K 0.01% 445
2021
Q2
$882K Buy
5,481
+1,696
+45% +$273K 0.02% 388
2021
Q1
$570K Buy
3,785
+1,217
+47% +$183K 0.02% 335
2020
Q4
$389K Buy
2,568
+488
+23% +$73.9K 0.02% 352
2020
Q3
$282K Sell
2,080
-2,012
-49% -$273K 0.01% 348
2020
Q2
$559K Buy
+4,092
New +$559K 0.03% 221
2019
Q2
Sell
-1,984
Closed -$222K 450
2019
Q1
$222K Buy
+1,984
New +$222K 0.01% 362
2016
Q4
Sell
-5,907
Closed -$570K 248
2016
Q3
$570K Buy
+5,907
New +$570K 0.06% 165
2015
Q4
Sell
-24,399
Closed -$2.47M 480
2015
Q3
$2.47M Buy
24,399
+5,679
+30% +$574K 0.45% 25
2015
Q2
$2.3M Buy
+18,720
New +$2.3M 0.29% 82